Antibody Drug Conjugates for Cancer Therapy | Pharmacological Reviews
Clinical pharmacology of vc-MMAE antibody-drug conjugates in cancer patients: learning from eight first-in-human Phase 1 studies. - Abstract - Europe PMC
Anti-Monomethyl auristatin E (MMAE) monoclonal antibody(mAb) : Products and Application | GeneMedi
Generation of the potent antibody-drug conjugate trastuzumab-(LAP·MMAE)... | Download Scientific Diagram
Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistance | Nature Communications
Physical characteristics comparison between maytansinoid-based and auristatin-based antibody-drug conjugates
Anti-MMAE (Monomethyl auristatin E) Antibodies and MMAE Conjugates: For PK/PD Studies on MMAE-ADC - Creative Diagnostics
Monomethyl auristatin antibody and peptide drug conjugates for trimodal cancer chemo-radio-immunotherapy | Nature Communications
Preparation of the Val‐Cit‐MMAE antibody‐drug conjugate (ADC) and drug... | Download Scientific Diagram
Anti-MMAE antibody(8B4); Rabbit mAb - DIMA Biotechnology
Therapeutic Potential of MF-TTZ-MMAE, a Site-Specifically Conjugated Antibody-Drug Conjugate, for the Treatment of HER2-Overexpressing Breast Cancer | Bioconjugate Chemistry
Microtubule and tubulin binding and regulation of microtubule dynamics by the antibody drug conjugate (ADC) payload, monomethyl auristatin E (MMAE): Mechanistic insights into MMAE ADC peripheral neuropathy - ScienceDirect
PEPTIDES & ANTIBODIES - Peptides in Antibody & Peptide Drug Conjugates